Abstract
Circulating microRNA are promising diagnostic and prognostic biomarkers of disease in quantitative blood tests. A label-free, PCR-free, electrochemical microarray technology on a monolith electrode is described, with 10 attomolar (aM) sensitivity and responsiveness to binding of <1 zeptomole of target to immobilized ssDNA probes with zero background. Specificity is 100 % in a mixture with five nonspecific miRNA each with a 103-fold higher concentration. Direct measurement on plasma-derived miRNA without cDNA conversion and PCR demonstrated multiplexing and near-ideal quantitative correlation with an equivalent pure sample. The dynamic range is a target concentration ranging from 10−2 to 103 femtomolar (fM). This PCR-free novel technology can be applied as a test for cancer diagnosis/prognosis to detect 103 copies of a miRNA sequence in RNA extracted from 100 μL of plasma.
Original language | English (US) |
---|---|
Pages (from-to) | 429-433 |
Number of pages | 5 |
Journal | ChemElectroChem |
Volume | 5 |
Issue number | 3 |
DOIs | |
State | Published - Feb 2018 |
Keywords
- DNA sequencing
- blood test
- cancer diagnosis
- electrochemical analysis
- microRNA
- microarray
ASJC Scopus subject areas
- Catalysis
- Electrochemistry